HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 15 and 34 years old
- People who speak English
- People who have recently started taking PrEP (an HIV prevention medication) for the first time within the last 30 days, or who have restarted PrEP after a break of at least 1 month
- People who have tested HIV negative, as confirmed by a doctor and their medical records
- People who are able to give their consent to participate and do not have cognitive or medical conditions that would affect their ability to do so, as assessed by a clinician
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larry K Brock, MD, Rhode Island Hospital
Phone: (401)-455-6375
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tenofovir (TFV) blood concentration at 24 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.